@WHO: While it is clear that convalescent plasma has no benefit in non-severe #COVID19 patients, the evidence is less certain in the case of of severe and critically ill patients. So randomized clinical trials for these subgroups should continue https://t.co/Bobq7OTDGq https://t.co/ihScqP5PKV

@WHO: While it is clear that convalescent plasma has no benefit in non-severe #COVID19 patients, the evidence is less certain in the case of of severe and critically ill patients. So randomized clinical trials for these subgroups should continue https://t.co/Bobq7OTDGq https://t.co/ihScqP5PKV

http://twitter.com/WHO
via IFTTT

Comments